Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Clarivate Insights
December 16, 2022
Intellectual Property
December 15, 2022
Life Sciences and Healthcare
December 6, 2022
Clarivate Insights
November 22, 2022